Savient Pharmaceuticals (SVNTQ) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock SVNTQ Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Promising Market Potential and Efficacy of Syndax Pharmaceuticals’ Revumenib Justify Buy RatingNovember 12, 2024 | markets.businessinsider.comStevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024October 22, 2024 | businesswire.comMilestone Pharmaceuticals’ CARDAMYST: A Game Changer in PSVT Treatment with Significant Market PotentialOctober 14, 2024 | markets.businessinsider.comZantac’s Developer Settles Lawsuits Claiming Cancer LinkOctober 10, 2024 | nytimes.comAcumen Pharmaceuticals Extends Collaboration with Lonza to Add Drug Product Manufacturing of Sabirnetug for Early Alzheimer's DiseaseSeptember 26, 2024 | tmcnet.comTruliant Consulting launches a white paper on Artificial Intelligence in PharmacovigilanceSeptember 19, 2024 | tmcnet.comBuy Rating Affirmed for Aquestive Therapeutics on Strong Phase 3 Results for Anaphylm™ with Raised Price TargetMarch 18, 2024 | markets.businessinsider.comQuoin Pharmaceuticals Prices Offering Of Approx. 4.1 Mln Shares At $1.6/Share; Stock TanksMarch 5, 2024 | nasdaq.comCrude Oil Down Over 1%; Quoin Pharmaceuticals Shares Spike HigherMarch 4, 2024 | msn.comCorvus Pharmaceuticals Presents Soquelitinib Preclinical Data at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory DiseasesFebruary 12, 2024 | markets.businessinsider.comIndia's Torrent Pharma posts higher Q3 profit on strong domestic demandFebruary 2, 2024 | reuters.comDevonian Seeks Shareholders Approval for Share ConsolidationJanuary 19, 2024 | businesswire.com4 Pharma Stocks to Buy, According to an Analyst. Novo Nordisk Isn’t One.January 16, 2024 | msn.comSail Biomedicines Appoints Tech and Pharma Industry Veteran Frank D'Amelio to Its BoardJanuary 4, 2024 | tmcnet.comThe Analyst Verdict: Rhythm Pharmaceuticals In The Eyes Of 7 ExpertsJanuary 4, 2024 | benzinga.comCorvus Pharmaceuticals Presents New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma TrialDecember 9, 2023 | tmcnet.comAbbVie Makes Another Big Pharma Acquisition. How It’s Putting Its Cash to Work.December 7, 2023 | msn.comFosun Pharma USA Announces Abstract to be Presented at IASLC 2023 North America Conference on Lung Cancer (NACLC)November 28, 2023 | benzinga.comSavient Pharmaceuticals Inc (SVNT)October 22, 2023 | investing.comPharma Logistics Awarded Department of Defense Contract for Pharmaceutical Reverse Distribution ServicesOctober 3, 2023 | businesswire.comDisposition of Common Shares of Small Pharma Inc.October 2, 2023 | benzinga.comLife Pharma inks distribution pact with pharmaceutical major PharmEvo of PakistanSeptember 30, 2023 | msn.comAnnexin announces success in the company's cancer initiativeSeptember 29, 2023 | benzinga.comAvalyn Pharma's CEO Leads Workshop on Clinical Strategy at IPF SummitSeptember 18, 2023 | technews.tmcnet.comScinai Immunotherapeutics Shares Fall Premarket After Stock Offering >SCNISeptember 16, 2023 | marketwatch.comUSFDA issues warning letter to Intas Pharma for Sanand plantAugust 6, 2023 | msn.comTerns Pharmaceuticals (TERN) Receives a Buy from Mizuho SecuritiesAugust 3, 2023 | markets.businessinsider.comQuoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2023 Financial ResultsAugust 3, 2023 | technews.tmcnet.comWhat to know about Manitowoc's first Narcan vending machineAugust 2, 2023 | news.yahoo.comABVC BioPharma Announces Reverse Stock SplitJuly 24, 2023 | benzinga.comSavient Stock Hits New 52-Week Low (SVNT)April 1, 2023 | thestreet.com10 Most Shorted Stocks in BiotechMarch 29, 2023 | thestreet.com Get Savient Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SVNTQ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SVNTQ Media Mentions By Week SVNTQ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SVNTQ News Sentiment▼0.001.39▲Average Manufacturing News Sentiment SVNTQ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SVNTQ Articles This Week▼00▲SVNTQ Articles Average Week Get the Latest News and Ratings for SVNTQ and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Savient Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies FFNTF News Today AIMDW News Today AGNPF News Today ALST News Today AZNCF News Today AVXT News Today BCTXW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SVNTQ) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenIf you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop fi...Neuro Street Trading Academy | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.For the everyday American who's worked hard to build their nest egg, Trump preserved a IRS loophole that allow...American Hartford Gold | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Savient Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Savient Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
